Frontlight ResearchEarly access
CompletedNo phase
Low Level Laser VS Transcutaneous Vagus Nerve Stimulation on Vascular Changes in Patients With Diabetic Polyneuropathy
Key facts
- Who runs it
- Horus University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 1 Aug 2025
- Ended
- 1 Mar 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Low level laser
- Transcutaneous auricular Vagus nerve stimulation
- Record updated
- 20 May 2026
Who can take part
- Age
- 45 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- The patient selection will be according to the following criteria:
- 30 patients diagnosed with diabetic neuropathy from both genders their ages will be ranged from 45-60 years old
- All patients are ambulant independently
- All patients are under full medical control
- Glycated hemoglobin is ranged from 6.5: 7 %
- Patients have had diabetes for more than 5 or 10 years
- patients experiencing painful peripheral neuropathic symptoms for more than 6 months involving both lower extremities and complained of burning pain with paresthesia in both legs; 7 Neurological examination revealed abnormal sensation appeared at the ends of the extremities
Who cannot take part
- Nerve damage as a result of prior reconstructive or replacement knee surgery, back surgery, spinal stenosis, spinal compression or radiculopathy
- Patients had unstable glycemic control and/or medical conditions that would confound assessment of neuropathy such as malignancy, active/untreated thyroid disease, peripheral vascular diseases, vascular insufficiency (claudication, skin discoloration, ulceration)
- Following the implantation of cardiac pacemakers or other electrical stimulation devices
- Patients whose heart rate dropped below 50 beats/min after vagus nerve stimulation
- Patient had sinus bradycardia, long QT syndrome, or other arrhythmias or mental disorders
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To compare the effect of both low-level laser versus transcutaneous vagus nerve stimulation on vascular changes in patients with diabetic polyneuropathy
The 2 groups in the trial
- Low Level LaserTreatment being tested
Patients will receive Low Level Laser irradiated with two wavelengths of visible 630 nm and near infra-red 810 nm for 15 min on entire surface of each foot three times a week for 2 months
- Transcutaneous auricular Vagus nerve stimulationExisting treatment, for comparison
Patients will receive 30 minutes Transcutaneous auricular Vagus nerve stimulation 3 sessions per week for 2 months.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Low Level Laser Versus Transcutaneous Vagus Nerve Stimulation on Vascular Changes in Patients With Diabetic Polyneuropathy
- Record updated
- 20 May 2026